OncBioMune
OncBioMune is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapy products. The company specializes in creating medicines and vaccines designed to stimulate the immune system, enabling it to selectively target and attack cancer cells while minimizing harm to healthy tissue. Its lead product, ProscaVax, is currently undergoing phase 2 clinical trials for the treatment of prostate cancer. Additionally, OncBioMune is involved in developing targeted therapies and has established a partnership with Perthera, Inc. to enhance access to its phosphoprotein panel, the Theralink assay, for breast cancer patients. Founded in 2005 and headquartered in Baton Rouge, Louisiana, OncBioMune aims to advance novel treatment options for various cancers.
Vitel Laboratorios S.A. de C.V. is a pharmaceutical company based in Mexico City, Mexico, established in 2016. The company focuses on the research, development, purchase, distribution, co-marketing, and co-promotion of high specialty pharmaceutical products within Mexico. Vitel Laboratorios operates as a subsidiary of OncBioMune Pharmaceuticals, Inc. and is dedicated to advancing the availability of specialized medications in the healthcare market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.